- Report
- March 2025
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 169 Pages
Global
From €2210EUR$2,325USD£1,857GBP
€4421EUR$4,650USD£3,714GBP
- Report
- December 2023
- 200 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 86 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2025
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- March 2023
- 223 Pages
Global
From €3394EUR$3,570USD£2,851GBP
The Central Lab market within the context of Drug Discovery is a specialized segment of the pharmaceutical industry that provides services to support the development of new drugs. Central Labs provide a range of services, including sample collection, sample analysis, and data management. These services are essential for drug development, as they enable researchers to collect and analyze data from clinical trials and other studies. Central Labs also provide a range of other services, such as quality control, regulatory compliance, and data management.
The Central Lab market is highly competitive, with a number of companies offering services to support drug discovery. Some of the major players in the market include Covance, PPD, Charles River Laboratories, and LabCorp. Other companies in the market include Quintiles, ICON, and Wuxi AppTec. Show Less Read more
